Aix-Marseille Univ UM 2, Centre d'Immunologie de Marseille-Luminy Marseille, France.
Front Cell Infect Microbiol. 2013 Jul 8;3:28. doi: 10.3389/fcimb.2013.00028. eCollection 2013.
Several bacterial pathogens have TIR domain-containing proteins that contribute to their pathogenesis. We identified a second TIR-containing protein in Brucella spp. that we have designated BtpB. We show it is a potent inhibitor of TLR signaling, probably via MyD88. BtpB is a novel Brucella effector that is translocated into host cells and interferes with activation of dendritic cells. In vivo mouse studies revealed that BtpB is contributing to virulence and control of local inflammatory responses with relevance in the establishment of chronic brucellosis. Together, our results show that BtpB is a novel Brucella effector that plays a major role in the modulation of host innate immune response during infection.
几种细菌病原体含有 TIR 结构域蛋白,这些蛋白有助于其发病机制。我们在布鲁氏菌属中鉴定出第二种含有 TIR 结构域的蛋白,我们将其命名为 BtpB。我们发现它是 TLR 信号的有效抑制剂,可能通过 MyD88 发挥作用。BtpB 是一种新型布鲁氏菌效应蛋白,可被转运至宿主细胞,并干扰树突状细胞的激活。体内小鼠研究表明,BtpB 有助于毒力和局部炎症反应的控制,这与慢性布鲁氏菌病的建立有关。总之,我们的研究结果表明,BtpB 是一种新型布鲁氏菌效应蛋白,在感染过程中宿主固有免疫反应的调节中发挥重要作用。